Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
Stat
Tue, 02/4/20 - 10:04 am
biotech
Jeff Leiden
Vertex Pharmaceuticals
Herb Boyer
Bob Swanson
Genentech
Amgen
George Rathmann
Gordon Binder
Vertex drops VX-961 to continue search for perfect pain drug
Fierce Biotech
Fri, 01/31/20 - 11:06 am
Vertex Pharmaceuticals
VX-961
painkillers
Vertex impresses with strong Trikafta launch
BioPharma Dive
Thu, 01/30/20 - 09:26 pm
Vertex Pharmaceuticals
drug launches
cystic fibrosis
Trikafta
earnings
Are Biotech Stocks Due for a Correction in 2020?
Motley Fool
Thu, 01/16/20 - 10:08 am
biotech stocks
Axsome Therapeutics
Seattle Genetics
Vertex Pharmaceuticals
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
Endpoints
Mon, 01/13/20 - 11:53 pm
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2020
Gilead Sciences
M&A
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
Sat, 01/11/20 - 11:02 pm
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
The 4 biggest pharma market access stories of 2019
Pharmaforum
Thu, 12/19/19 - 12:16 am
biosimilars
UK
Orkambi
Vertex Pharmaceuticals
drug pricing
FDA
NICE
5 New Drug Approvals the FDA Gave Top Priority
Motley Fool
Sat, 11/30/19 - 11:22 pm
FDA
drug approvals
Global Blood Therapeutics
Oxbryta
Alnylam
Givlaari
BeiGene
Brukinsa
Vertex Pharmaceuticals
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
RAPS.org
Wed, 11/27/19 - 12:39 pm
FDA
Vertex Pharmaceuticals
Trikafta
Novartis
Adakveo
Alnylam
Givlaari
BeiGene
Brukinsa
Global Blood Therapeutics
Oxbryta
drug approvals
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
BioCentury
Tue, 11/5/19 - 10:20 am
Vertex Pharmaceuticals
FDA
cystic fibrosis
Trikafta
A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal
Endpoints
Mon, 10/28/19 - 10:54 am
Vertex Pharmaceuticals
CRISPR
gene editing
CTX001
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
Stat
Thu, 10/24/19 - 10:31 am
Vertex Pharmaceuticals
cystic fibrosis
UK
‘A game-changer’: How Vertex delivered on cystic fibrosis
Stat
Wed, 10/23/19 - 10:33 pm
Vertex Pharmaceuticals
cystic fibrosis
Trikafta
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
Stat
Mon, 10/21/19 - 04:33 pm
Vertex Pharmaceuticals
cystic fibrosis
FDA
Trikafta
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year
Motley Fool
Tue, 10/8/19 - 10:21 am
Vertex Pharmaceuticals
cystic fibrosis
gene editing
Vertex hits a biomarker bump on road to new drug
Biopharma Dive
Tue, 09/17/19 - 03:37 pm
Vertex Pharmaceuticals
AAT
VX-814
Vertex deal for Scotland — no deal for England
Endpoints
Fri, 09/13/19 - 10:22 am
Vertex Pharmaceuticals
cystic fibrosis
Scotland
England
UK
Symkevi
Orkambi
Don’t Blink or You’ll Miss Vertex’s Next Move, And It’s Bound to Be a Good One
Motley Fool
Wed, 09/4/19 - 11:31 pm
Vertex Pharmaceuticals
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Stat
Tue, 09/3/19 - 10:32 am
Vertex Pharmaceuticals
M&A
diabetes
type 1 diabetes
Semma Therapeutics
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »